CDK8 and breast carcinoma: miR-26a-5p was also confirmed to inhibit breast cancer cell growth by suppression of RNF6 expression (Huang et al., 2019); miR-26b-5p played a suppressive role in inhibiting proliferation of breast cancer cells by negatively regulating CDK8 (Li et al., 2014).